Arcadia Biosciences Inc (RKDA)
Official siteCONSUMER DEFENSIVE • PACKAGED FOODS • NASDAQ
Market Cap: $1.32M
Last updated: Nov 17, 2026 at 4:39 PM ET
Arcadia Biosciences Inc (RKDA) Stock Chart
Arcadia Biosciences (RKDA) has a latest price of $0.19 on Nov 17, 2026, 95.1% below its 52-week high of $3.87. Its price fell 95.0% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 59.4%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $1,296.00 in Oct 2016 and its lowest $0.16 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart RKDA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for RKDA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 57.1%, and over 6 months it fell 79.4%. The month-end price fell 95.4% over the 3 years through Oct 2026, a compound annual decline of 64.2%.
| Period | Change |
|---|---|
| 1 month | +30.8% |
| 3 months | -57.1% |
| 6 months | -79.4% |
| 12 months | -95.0% |
| 12 months, with dividends | -95.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -95.4% | -64.2% |
| 5 years | -99.8% | -71.1% |
| 10 years | -100.0% | -59.4% |
Price by Year
Its best calendar year was 2024, when the price rose 89.1%, and its weakest was 2022, when it fell 73.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.16 | -92.0% |
| 2025 | $1.98 | -66.6% |
| 2024 | $5.92 | +89.1% |
| 2023 | $3.13 | -71.1% |
| 2022 | $10.84 | -73.9% |
| 2021 | $41.60 | -58.9% |
| 2020 | $101.20 | -53.8% |
| 2019 | $219.20 | +72.9% |
| 2018 | $126.80 | -42.4% |
| 2017 | $220.00 | -70.1% |
Trading Range
The price is 28.1% below its 50-day average of $0.26 and 78.6% below its 200-day average of $0.89.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.19 | |
| 52-week high | $3.87 | -95.1% |
| 52-week low | $0.11 | +70.9% |
| 50-day average | $0.26 | -28.1% |
| 200-day average | $0.89 | -78.6% |
Price Risk
Over 3 years, its largest fall from a peak was 97.7%.
| Measure | Value |
|---|---|
| 1-year beta | 1.15 |
| Largest fall, 1 year | -96.2% |
| Largest fall, 3 years | -97.7% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About RKDA
What is RKDA's 1-year price change?
Arcadia Biosciences's price fell 95.0% over the past 12 months. With dividends included, the 12-month total return was -95.0%.
What is RKDA's 5-year price change?
Arcadia Biosciences's month-end price fell 99.8% over the 5 years through Oct 2026, a compound annual decline of 71.1%. These figures leave out dividends.
What is RKDA's 52-week high and low?
Arcadia Biosciences's 52-week high is $3.87 and its 52-week low is $0.11. Its latest price of $0.19 on Nov 17, 2026 is 95.1% below the high.
What is RKDA's beta?
Arcadia Biosciences's 1-year beta against the S&P 500 is 1.15, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 96.2%.
Is the RKDA chart free?
Yes. Advanced Charting for RKDA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
RKDA pages: Overview, Charting, Earnings, Financials, Statistics, Valuation, Competitors